Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft models.

Sci Rep · 2019 · PMC6904563 · PMID 31822716

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not achieve significanceno p-value reported

When pS6 expression was detected by AQUA analysis, it was reduced by PF-04691502 on Day 4 period and on Day 7 for gedatolisib, however these results did not achieve significance (Fig. 2B ).

also in 1,397 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.